Cetuximab 認識標靶藥品Cetuximab
2025/3/28
Cetuximab is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR) on cells. EGFR is found in large amounts on the surface of some cancer cells, resulting in tumors growing more quickly. By attaching to the EGFR, this drug blocks EGFR from receiving growth signals, preventing further cancer growth and slowing cancer progression.